Re: blind ffn article

From: Andrew Folley (agfolley@hotmail.com)
Fri Apr 8 15:35:57 2005


Dan, I think that this study at least suggests that blind sampling gives similar numbers and a similar negative predictave value to speculum exam. In other words with a negative FFN (blind or speculum) we see a 99% chance the pateitn will not deliver in next two weeks. andy

>From: "R. Daniel Braun" <rd.braun@gmail.com>
>Reply-To: ob-gyn-l@obgyn.net
>To: Multiple recipients of list OB-GYN-L <ob-gyn-l@dns.obgyn.net>
>Subject: Re: blind ffn article
>Date: Fri, 8 Apr 2005 06:37:02 -0500
>
>Not very helpful as it doesn't compare blind sampling to visual
>sampling. It appears to say that blind sampling may be better than NO
>sampling.
>
>Dan
>
>On Apr 7, 2005 7:43 PM, RModugno@aol.com <RModugno@aol.com> wrote:
> > Obstetrics & Gynecology 2005;105:285-289
> > (c) 2005 by The American College of Obstetricians and Gynecologists
> >
> > ________________________________
> >
> > ________________________________
> > ORIGINAL RESEARCH
> >
> > "Blind" Vaginal Fetal Fibronectin as a Predictor of Spontaneous Preterm
> > Delivery Ashley S. Roman, MD, MPH*, Nikki Koklanaris, MD*, Michael J.
> > Paidas, MD, Jeanine Mulholland, RN*, Mortimer Levitz, PhD* and Andrei
> > Rebarber, MD*
> >
> > From the *Department of Obstetrics and Gynecology, New York University
> > School of Medicine, New York, New York; and Department of Obstetrics and
> > Gynecology, Yale University School of Medicine, New Haven, Connecticut.
> >
> > Address reprint requests to: Ashley S. Roman, MD, MPH, 550 First Avenue,
>NB
> > 9E2, New York, NY 10016; e-mail: achapinsmith@aol.com .
> >
> > OBJECTIVE: To assess the accuracy of vaginal fetal fibronectin sampling
> > without use of a sterile speculum examination as a screening test for
> > predicting spontaneous preterm birth.
> >
> > METHODS: A historical cohort of patients who were followed up with
>serial
> > fetal fibronectin testing between 1998 and 2001 was identified. All
>patients
> > were considered to be at high risk for preterm delivery and were
>screened
> > with fetal fibronectin testing without using a speculum at 2- to 3-week
> > intervals from 22 weeks to 32 weeks of gestation. Charts were reviewed
>for
> > fetal fibronectin results and pregnancy outcome data. Groups were
>compared
> > using 2 analysis or Fisher exact test with significance defined as P <
>.05.
> >
> > RESULTS: A total of 1,396 fetal fibronectin tests from 416 pregnancies
>were
> > performed via the "blind" sampling technique. Overall, 24.9% of
>pregnancies
> > delivered spontaneously before 37 weeks; 9.1% delivered spontaneously
>before
> > 34 weeks. For delivery before 34 weeks of gestation, the test had a
> > sensitivity of 44.7%, a specificity of 88.4%, a positive predictive
>value of
> > 27.9%, and a negative predictive value of 94.1%. For delivery within 14
>and
> > 21 days of a single fetal fibronectin assessment, the test had a
>sensitivity
> > of 52% and 45.5%, a specificity of 94.5% and 94.9%, a positive
>predictive
> > value of 14.6% and 22.5%, and a negative predictive value of 99.1% and
> > 98.2%, respectively.
> >
> > CONCLUSION: "Blind" vaginal fetal fibronectin sampling has high negative
> > predictive values and specificities in predicting spontaneous preterm
>birth.
> >
> > LEVEL OF EVIDENCE: II-2
> >
>
>--
>R. Daniel Braun
> Kinky for Governor





use when must restrict search to only the ob-gyn-l forum...
Enter search keywords:
Returns per screen: Require all keywords:

Return to  OB-GYN-L Mail a New Message to the Forum: ob-gyn-l@obgyn.net
Forum Administrator: geffrey.klein@obgyn.net
Report Technical Problems: webmaster@obgyn.net
Last Updated: Wed Jul 2 04:39:23 2008

The American Medical Association is no longer designating CME hours for AMA Category II CME credit. However, physicians themselves may self designate learning activities as Category II CME credit hours if they feel it is of sufficient educational merit and meets the formal definitions of continuing medical education. OBGYN.net believes these interaction in this forum meets these criteria. For further information see the AMA web site.